Home
Angitia Biopharmaceuticals

Angitia Biopharmaceuticals Market Share Analysis for June 2026

angitia - innovation for patients

Industry: N/A

Domainangitiabio.com

Year Founded2018

Employees51 - 200

Annual Revenue$2M - $5M

Angitia Biopharmaceuticals

Angitia Biopharmaceuticals (including company regionals)

angitiabio.com

See more website traffic and engagement information

Angitia Biopharmaceuticals Revenue up to June 2026 is 2M - 5M

revenue generated by Angitia Biopharmaceuticals top domains

Angitia Biopharmaceuticals top domains revenue over 3 years

Revenue for Angitia Biopharmaceuticals top domains

angitiabio.com2M - 5M

See more with Sales Intelligence

Total visits to Angitia Biopharmaceuticals's top domains

Understand Angitia Biopharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

angitiabio.com4.4K

See more with Sales Intelligence

Avg. visit duration in Angitia Biopharmaceuticals's top domains

Analyze Angitia Biopharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

angitiabio.com00:00:15

See more with Sales Intelligence

Avg. pageviews on Angitia Biopharmaceuticals's top domains

See how Angitia Biopharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

angitiabio.com1.81

See more with Sales Intelligence

Angitia Biopharmaceuticals top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Angitia Biopharmaceuticals

These are the website technologies, by industry, used by Angitia Biopharmaceuticals top domains

Conversion & Analytics (3)

Cloudflare Insights

Widget (2)

Google Maps

Advertising (1)

PubMatic

Email Services (1)

Microsoft Exchange Online

More Technologies

2

See all

News & Signals from Angitia Biopharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAngitiabio receives financing of $130M in Series D.Angitia Biopharmaceuticals secures USD 130m Series D financing for musculoskeletal therapeutics.

NewsAngitiabio attended event American Society for Bone and Mineral Research 2025 Annual Meeting on Sep 5th '25.Westlake Village, California, USA, September 8, 2025 - Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases, today announced data from its ongoing program evaluating AGA2115 for the treatment of osteogenesis imperfecta (OI) at the American Society for Bone and Mineral Research 2025 Annual Meeting (ASBMR) September 5-8, 2025, in Seattle, WA.

NewsAngitiabio attended event ASBMR 2025 on Sep 5th '25.Angitia Biopharmaceuticals to present data on AGA2115 for Osteogenesis Imperfecta at ASBMR 2025.